|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2001-10-2
|
|
pubmed:abstractText |
Keratocytes give rise to fibroblasts and myofibroblasts in wounded cornea. It is well established that treatment of fibroblasts with transforming growth factor (TGF) beta will induce myofibroblast differentiation. We investigated whether this differentiation could be reversed by the administration of fibroblast growth factor (FGF).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Actins,
http://linkedlifedata.com/resource/pubmed/chemical/Activin Receptors, Type I,
http://linkedlifedata.com/resource/pubmed/chemical/Cadherins,
http://linkedlifedata.com/resource/pubmed/chemical/Connexin 43,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 1,
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2,
http://linkedlifedata.com/resource/pubmed/chemical/Heparin,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transforming Growth...,
http://linkedlifedata.com/resource/pubmed/chemical/TGF-beta type I receptor,
http://linkedlifedata.com/resource/pubmed/chemical/transforming growth factor-beta...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0146-0404
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2490-5
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11581188-Actins,
pubmed-meshheading:11581188-Activin Receptors, Type I,
pubmed-meshheading:11581188-Animals,
pubmed-meshheading:11581188-Blotting, Northern,
pubmed-meshheading:11581188-Blotting, Western,
pubmed-meshheading:11581188-Cadherins,
pubmed-meshheading:11581188-Cell Differentiation,
pubmed-meshheading:11581188-Cell Division,
pubmed-meshheading:11581188-Cells, Cultured,
pubmed-meshheading:11581188-Connexin 43,
pubmed-meshheading:11581188-Cornea,
pubmed-meshheading:11581188-Drug Combinations,
pubmed-meshheading:11581188-Fibroblast Growth Factor 1,
pubmed-meshheading:11581188-Fibroblast Growth Factor 2,
pubmed-meshheading:11581188-Fibroblasts,
pubmed-meshheading:11581188-Heparin,
pubmed-meshheading:11581188-Phenotype,
pubmed-meshheading:11581188-Protein-Serine-Threonine Kinases,
pubmed-meshheading:11581188-RNA, Messenger,
pubmed-meshheading:11581188-Rabbits,
pubmed-meshheading:11581188-Receptors, Transforming Growth Factor beta
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Fibroblast growth factor reversal of the corneal myofibroblast phenotype.
|
|
pubmed:affiliation |
Department of Ophthalmology, Mount Sinai School of Medicine of New York University, New York, New York 10029-6574, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
